Deal

ABBOTT LABORATORIES acquires Walk Vascular, LLC

September 2021 Full acquisition Ready
01 Scorecard

The deal at a glance

Private-market deal
ABBOTT LABORATORIES acquires Walk Vascular, LLC
Deal value
(not disclosed)
Sector
Medical devices — vascular
Date
September 2021
VectorShift
Made on VectorShift

ABBOTT LABORATORIES acquired Walk Vascular, LLC, a transaction completed in September 2021.

Walk Vascular, LLC operates in Medical devices — vascular, is based in Irvine, California, USA. Walk Vascular is a commercial-stage medical device company with a minimally invasive thrombectomy system designed to remove peripheral blood clots; its peripheral thrombectomy system has been incorporated into Abbott's existing endovascular portfolio.

Walk Vascular's peripheral thrombectomy system has been incorporated into Abbott's existing endovascular portfolio.

Commercial-stage peripheral thrombectomy system complementary to Abbott's endovascular portfolio. Integrated into Abbott's endovascular portfolio

In September 2021, Abbott acquired Walk Vascular, LLC (Walk Vascular), a commercial-stage medical device company with a minimally invasive thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy system has been incorporated into Abbott's existing endovascular portfolio.
Abbott FY2023 10-K, financial statements note
Advisors not disclosed

No advisory firms have been disclosed for this transaction.

See how VectorShift works for your firm

Request Demo